NovoCure (038) Q2 2024 Earnings Report
DE:038 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.28
- Consensus EPS
- -EUR 0.36
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 0.48
DE:038 Q2 2024 Revenue Results
- Actual Revenue
- EUR 134.63M
- Expected Revenue
- EUR 121.62M
- Beat/Miss
- Beat by +EUR 13.01M
- YoY Revenue Growth
- +19.28%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/25/2024
- Time
- Before Open
- Conference Call
- Thursday, July 25, 2024
DE:038 Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:038 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:038 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.20- | -0.2 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.21-0.08 | -0.3 | 72.73% (+0.21) | |
| Jul 23, 2026 | 2026 (Q2) | -0.30-0.12 | -0.32 | 63.89% (+0.21) | |
| Apr 30, 2026 | 2026 (Q1) | -0.46-0.56 | -0.28 | -100.00% (-0.28) | |
| Feb 26, 2026 | 2025 (Q4) | -0.37-0.20 | -0.55 | 63.93% (+0.35) | |
| Oct 30, 2025 | 2025 (Q3) | -0.38-0.30 | -0.25 | -17.86% (-0.04) | |
| Jul 24, 2025 | 2025 (Q2) | -0.34-0.32 | -0.28 | -16.13% (-0.04) | |
| Apr 24, 2025 | 2025 (Q1) | -0.42-0.28 | -0.32 | 13.89% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | -0.31-0.55 | -0.4 | -35.56% (-0.14) | |
| Oct 30, 2024 | 2024 (Q3) | -0.30-0.25 | -0.41 | 39.13% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
